Literature DB >> 25270839

[Olfactory disorders and their therapy].

A Hähner1, T Hummel, B A Stuck.   

Abstract

Among the main causes of olfactory disorders are chronic rhinosinusitis, head trauma, acute infections of the upper respiratory tract and neurodegenerative diseases. Olfactory disorders can impose major restrictions on our lives. Although there are numerous approaches for the therapy of olfactory disorders, double-blind comparison studies are needed to distinguish between the effects of these therapies and spontaneous remission of olfactory disorders. The most significant aspects of treatments seem to be anti-inflammatory measures and the regenerative capabilities of the olfactory neuroepithelium.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25270839     DOI： 10.1007/s00106-014-2924-3

Source DB:  PubMed          Journal:  HNO        ISSN： 0017-6192            Impact factor:   1.284


  37 in total

1.  Mometasone furoate nasal spray improves olfactory performance in seasonal allergic rhinitis.

Authors:  B A Stuck; A Blum; A E Hagner; T Hummel; L Klimek; K Hörmann
Journal:  Allergy       Date:  2003-11       Impact factor: 13.146

2.  Assessment of olfactory function after septoplasty: a longitudinal study.

Authors:  O Pfaar; K B Hüttenbrink; T Hummel
Journal:  Rhinology       Date:  2004-12       Impact factor: 3.681

3.  Sensory- and memory-mediated olfactory dysfunction in Huntington's disease.

Authors:  S Nordin; J S Paulsen; C Murphy
Journal:  J Int Neuropsychol Soc       Date:  1995-05       Impact factor: 2.892

4.  An open-label controlled trial of theophylline for treatment of patients with hyposmia.

Authors:  Robert I Henkin; Irina Velicu; Loren Schmidt
Journal:  Am J Med Sci       Date:  2009-06       Impact factor: 2.378

5.  Olfactory function and disease severity in chronic rhinosinusitis.

Authors:  Jamie R Litvack; Jess C Mace; Timothy L Smith
Journal:  Am J Rhinol Allergy       Date:  2009 Mar-Apr       Impact factor: 2.467

6.  Recovery of olfactory function following closed head injury or infections of the upper respiratory tract.

Authors:  Jens Reden; Antje Mueller; Christian Mueller; Iordanis Konstantinidis; Johannes Frasnelli; Basile N Landis; Thomas Hummel
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2006-03

7.  Prevalence of smell loss in Parkinson's disease--a multicenter study.

Authors:  A Haehner; S Boesveldt; H W Berendse; A Mackay-Sim; J Fleischmann; P A Silburn; A N Johnston; G D Mellick; B Herting; H Reichmann; T Hummel
Journal:  Parkinsonism Relat Disord       Date:  2009-01-11       Impact factor: 4.891

8.  The quinoxaline derivative caroverine in the treatment of sensorineural smell disorders: a proof-of-concept study.

Authors:  Christian Quint; Andreas F P Temmel; Thomas Hummel; Klaus Ehrenberger
Journal:  Acta Otolaryngol       Date:  2002-12       Impact factor: 1.494

9.  Olfactory training is helpful in postinfectious olfactory loss: a randomized, controlled, multicenter study.

Authors:  Michael Damm; Louisa K Pikart; Heike Reimann; Silke Burkert; Önder Göktas; Boris Haxel; Sabine Frey; Ioannis Charalampakis; Achim Beule; Berthold Renner; Thomas Hummel; Karl-Bernd Hüttenbrink
Journal:  Laryngoscope       Date:  2013-09-19       Impact factor: 3.325

10.  Olfactory training in patients with Parkinson's disease.

Authors:  Antje Haehner; Clara Tosch; Martin Wolz; Lisa Klingelhoefer; Mareike Fauser; Alexander Storch; Heinz Reichmann; Thomas Hummel
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240
View more
  2 in total

1.  [Adaptive desensitization for acetylsalicylic acid hypersensitivity: A success story?].

Authors:  G Mühlmeier; R Hausch; H Maier
Journal:  HNO       Date:  2015-10       Impact factor: 1.284

2.  [Olfactory and gustatory disorders].

Authors:  M M Speth; U S Speth; A R Sedaghat; T Hummel
Journal:  HNO       Date:  2022-01-12       Impact factor: 1.284
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.